My watch list
my.bionity.com  
Login  

Alzheimer’S Disease

News Alzheimer’S Disease

  • neotiv secures seed funding from High-Tech Gründerfonds

    From basic research straight to a digital medical product: this vision has been turned into reality by neotiv. The team headed by Chief Executive Officer Dr. Chris Rehse and dementia researcher Prof. Emrah Düzel develops user-friendly apps that are able to measure the psychological effects of Alzhei more

  • Alzheimer's drug turns back clock in powerhouse of cell

    The experimental drug J147 is something of a modern elixir of life; it's been shown to treat Alzheimer's disease and reverse aging in mice and is almost ready for clinical trials in humans. Now, Salk scientists have solved the puzzle of what, exactly, J147 does. They report that the drug binds to a more

  • Research opens new avenue for treatment of Alzheimer’s disease

    University of Florida neuroscientists have validated a potential pathway to halt the progression of Alzheimer’s disease, a debilitating neurodegenerative disorder that affects millions of Americans and is the most common cause of dementia. The investigators made the finding while studying the toxici more

All news on alzheimer’s disease

Videos Alzheimer’S Disease

Chaperones - folding helpers in the cell

Nothing works without the correct form: For most proteins, there are millions of ways in which these molecules, composed of long chains of amino acids, can be folded - but only one way is the right one. Researchers in the department "Cellular Biochemistry" at the Max Planck Institute for Biochem ... more

Events Alzheimer’S Disease

Conference
05-03 – 08-03
2018
Cancún, MX

Genomic Instability and Gene Therapeutics in Neurological Diseases Conference

With the rapidly emerging new tools including genomics, bioinformatics, metabolomics and proteomic analysis and new powerful editing tools such as CRISPR/CAS9 we are getting closer to more defined understanding of the complex cellular pathways underpinning neurodegeneration, which underlie many debi

Conference
01-06 – 04-06
2018
Nassau, BS

Targeting Therapy of Alzheimer’s and Related Neurodegenerative Diseases

Alzheimer’s disease (AD) is the most common age-dependent neurodegenerative disease, which affects over 5 million people in the US and over 35 million people worldwide. Currently, only four drugs are approved for alleviating symptoms in AD patients, and no new therapy has been approved for AD since

Conference
05-08 – 10-08
2018
Castelldefels, ES

Neurobiology of Brain Disorders

It is increasingly being recognized that there is significant interplay between all the different brain cell types including neurons, astrocytes, microglia, pericytes, and endothelial cells that influence neurodegeneration. Not only do these different cell types interact in important ways but fluid

All events on alzheimer’s disease

Publications Alzheimer’S Disease

All publications on alzheimer’s disease
Related topics
Definition

Alzheimer's disease

Alzheimer's disease Alzheimer's disease (AD), also called Alzheimer disease, and simply known as Alzheimer's, is a neurodegenerative disease that, in its most common form, is found in people over the age of 65. Approximately 24 million people ... more

Watchlist

This is where you can add this topic to your personal favourites

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE